Live news related to BIOSYNEX stock (FR0011005933): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on BIOSYNEX mainly cover M&A activity, analyst notes et earnings publications. The stock trades at €0,82 on Euronext Paris, down 3,06% at the last update. This page lists the articles published on BIOSYNEX stock to track the share price, company announcements and any item likely to influence market perception.
Biosynex announced on October 23, 2026 that its American subsidiary Chembio Diagnostic Systems has secured funding for a rapid test capable of detecti…
Biosynex published on October 21, 2026 its accounts for the first half of 2026 and its third-quarter revenue, just days after its exit from safeguard …
By judgment handed down on October 12, 2026, the Strasbourg court ended the safeguard proceedings opened on September 29, 2025 for the diagnostic test…
The share of the Alsatian diagnostic test manufacturer posts spectacular gains during trading, amid ongoing creditor voting on a restructuring plan co…
The co-founder of Biosynex has submitted his resignation from his positions as Deputy Chief Executive Officer and Board Member, with an effective date…
Biosynex climbs 2.64% this Thursday mid-morning, reaching €0.856. This rebound follows the announcement of the Strasbourg-based rapid diagnostic test …
Biosynex shares advanced 2.59% by midday on Tuesday, March 17, trading at 0.872 euros after closing at 0.85 euros the previous day. This rebound is pa…
